Evidence mapPaperPMID 41267194Full record

ArticleCPT: pharmacometrics & systems pharmacology2026

Exposure-Response Analysis for Time-to-Event Data in the Presence of Adaptive Dosing: Efficient Approaches and Pitfalls.

Alexandra Lavalley-Morelle, Félicien Le Louedec, Richard Anziano, France Mentré, Martin Bergstrand

Abstract read
In one paragraph

Article in CPT: pharmacometrics & systems pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexandra Lavalley-MorellePharmetheus A.B., Uppsala, Sweden.ORCID https://orcid.org/0000-0001-5485-5694
Félicien Le LouedecPharmetheus A.B., Uppsala, Sweden.
Richard AnzianoPharmetheus A.B., Uppsala, Sweden.
France MentréUniversité Paris Cité, IAME, INSERM, Paris, France.ORCID https://orcid.org/0000-0002-7045-1275
Martin BergstrandPharmetheus A.B., Uppsala, Sweden.ORCID https://orcid.org/0000-0002-0295-1227

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Analyzing exposure-response (E-R) relationships for time-to-event (TTE) endpoints presents challenges due to the inherent time-dependent nature of the data. Some authors address these difficulties by using a fixed timepoint approach, where exposure is assessed at a predetermined time rather than dynamically over time. (e.g., initial exposure or last exposure). The aim of the current work is to compare the use of time-static and time-varying metrics to assess the E-R relationship through simulations. PK exposures were simulated from a one-compartment model and TTE data from a parametric proportional hazard model, involving the weekly average PK concentration as a time-varying covariate. Several scenarios were considered to handle the type of dosing (fixed or adaptive), the accumulation of the drug (low or strong), the type of event (efficacy, safety or independent), and the timing of the event onset (early or late). Wald tests on the exposure effect parameter were performed to assess the significance of the E-R relationship. For each simulation scenario, the type-I error and the power of the Wald tests were reported, revealing that no time-static metric consistently produced reliable results across all conditions. In order to ensure adequate statistical properties, we recommend using time-varying exposure, which shows good performance across all scenarios.

Indexed as

Models, BiologicalPharmacokineticsComputer SimulationDose-Response Relationship, DrugHumansProportional Hazards ModelsTime Factorsadaptive designdose reductionsdrug accumulationexposure‐responsetime‐static metricstime‐to‐event modelingtime‐varying exposure

Identifiers

PMID41267194
PMCPMC12823327

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.